Conclusions: Meta-analysis shows in older subjects with obesity that enobosarm 3mg daily treatment resulted in DEXA body composition changes of greater total weight loss by day 147 with ...

The multi-site international study led by Dr. Beth Overmoyer of the Dana-Farber Cancer Institute of Boston U.S. evaluated the efficacy and safety of enobosarm in 136 postmenopausal women with ...

About Veru Inc. Veru is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of metabolic diseases, oncology, and ARDS. The Company’s drug ...